WARSAW, Ind. & SUNRISE, Fla.--()--Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, and OrthoSensor™, a leader in intelligent orthopedics, are pleased to announce a co-promotion partnership with Biomet’s Vanguard® Complete Knee System and OrthoSensor’s VERASENSE™.
“Biomet is thrilled with its relationship with OrthoSensor and is excited to add this sensor technology to our Vanguard® Knee platform. We believe that the impact this will have on soft tissue balancing will be dramatic.”
OrthoSensor™ VERASENSE™ is a trial bearing designed for use with the Vanguard® Complete Knee System, which is embedded with sensors and microelectronics to provide surgeons with real-time knee kinetic data. The sensors wirelessly transmit information to a graphic display, allowing surgeons to quantify soft-tissue loads throughout the range of motion. This enables the surgeon to make informed adjustments to the soft tissues and implant placement in order to allow for overall knee balancing. Research has shown that soft tissue balance may aid in the reduction of pain, polyethylene wear, and aseptic loosening while improving patients’ proprioception.1
Jay Pierce, CEO of OrthoSensor, stated, “Combining Biomet’s Vanguard® Knee System with VERASENSE™ takes knee replacement surgery to a new level of precision by providing surgeons with actionable, intraoperative data to quantify and verify that they balance a knee implant properly during total knee replacement surgery. We are extremely pleased to partner with Biomet and expand access to OrthoSensor’s technology for surgeons using the Vanguard® system.”
Todd O. Davis, Biomet General Manager and Vice President of Global Knees, commented, “Biomet is thrilled with its relationship with OrthoSensor and is excited to add this sensor technology to our Vanguard® Knee platform. We believe that the impact this will have on soft tissue balancing will be dramatic.”
Biomet, Inc. (www.biomet.com) and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses large joint reconstructive products, including orthopedic joint replacement devices, and bone cements and accessories; sports medicine, extremities and trauma products, including internal and external orthopedic fixation devices; spine and bone healing products, including spine hardware, spinal stimulation devices, and orthobiologics, as well as electrical bone growth stimulators; dental reconstructive products; and other products, including microfixation products and autologous therapies. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.
OrthoSensor, Inc. (www.orthosensor.com) is an innovative medical device company developing and commercializing intelligent orthopedic devices that provide real-time data to surgeons and hospitals during and after surgery. OrthoSensor’s intelligent orthopedic devices utilize advanced sensor and wireless communication technology with the goal of improving healthcare outcomes and reducing the cost of treating musculoskeletal disease. The company’s intelligent orthopedic instrumentation and implants are designed to enhance surgical implantation, as well as enable remote monitoring of implant function and overall musculoskeletal health.
1 Babazadeh S, Stoney JD, Lim K, Choong PF. The relevance of ligament balancing in total knee arthroplasty: how important is it? A systematic review of the literature. Orthop Rev (Pavia). 2009 Oct 10;1(2).
All trademarks herein are the property of Biomet, Inc., or its
subsidiaries, unless otherwise indicated.
OrthoSensor is a trademark of OrthoSensor, Inc.
VERASENSE is a trademark of OrthoSensor, Inc.
FDA 510(k) pending.